NxStage Stock Receives a Third Buy Rating in a Row

BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.

Read the full article » | Posted 04-12-2017

Related Articles

• Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
• The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
• The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
• On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026